Evidence map›Paper›PMID 16708385›Full record

ArticleInternational journal of cancer2006

HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.

Michael A James, John H Lee, Aloysius J Klingelhutz

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Human papillomavirus and lung cancinogenesis: an overview.Journal of cancer research and clinical oncology · 2016
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael A JamesDepartment of Microbiology and Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
John H Lee
Aloysius J Klingelhutz
University of Iowa · US

Funding

OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLSR01AG018265 · NIA · UNIVERSITY OF IOWA · PI KLINGELHUTZ, ALOYSIUS JOHN · 2000 to 2004
$1.2M
NIA NIH HHS R01 AG018265NIA NIH HHS R01 AG18265
6 · The paper itself

Abstract

The E6 oncoprotein from high-risk HPV types activates human telomerase reverse transcriptase (hTERT) transcription in human keratinocytes. Studies on how E6 regulates hTERT have implicated E-box or X-box elements in the hTERT promoter (Veldman et al., Proc Natl Acad Sci USA 2003;100:8211-14; Oh et al., J Virol 2001;75:5559-66; Gewin et al., Genes Dev 2004;18:2269-82), but the mechanism of activation by E6 is still controversial and not well defined. Here, we demonstrate that induction of both hTERT expression and telomerase activity by HPV-16 E6 in early passage keratinocytes is associated with acetylation of histone H3 at the hTERT promoter, is dependent on the E6 associated protein (E6AP) and is not exclusively reliant on E-box or X-box elements. Further increases in histone acetylation of the hTERT promoter and hTERT transcriptional activity in E6 expressing cells that had been passaged extensively in culture were found to occur only with the endogenous promoter and not with an exogenously introduced hTERT promoter construct. Telomerase activity at both early and late passages, however, was dependent on E6AP expression, implying a continued reliance on E6 function for telomerase activity. Our results demonstrate that E6 induces hTERT promoter acetylation, but that further increases in telomerase activity and histone acetylation in later passage E6 expressing cells are independent of E6 activation of the core hTERT promoter. We also provide evidence that the transcription factor p300 is a potential repressor of telomerase activation and histone acetylation in the context of E6 expression. These studies give insight into how immortalization by HPV results in upregulation of hTERT and furthers our understanding of how telomerase is activated during the process of malignant transformation.

Indexed as

AcetylationCells, CulturedCellular SenescenceDNA-Binding ProteinsE-Box ElementsHistonesHumansOncogene Proteins, Viralp300-CBP Transcription FactorsPromoter Regions, GeneticRepressor ProteinsTelomeraseUbiquitin-Protein LigasesDNA-Binding ProteinsE6 protein, Human papillomavirus type 16HistonesOncogene Proteins, Viralp300-CBP Transcription FactorsRepressor ProteinsTelomeraseUBE3A protein, humanUbiquitin-Protein Ligases

Identifiers

PMID16708385
PMCPMC2223064
OpenAlexW2055689209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.